COVID-19 -- Worldwide/Unknown
Objectives: Characterisation of the human antibody response to SARS-CoV-2 infection is vital for serosurveillance purposes and for treatment options such as transfusion with convalescent plasma or immunoglobulin products derived from convalescent plasma. In this study, we longitudinally and quantitatively analysed antibody responses in RT-PCR-positive SARS-CoV-2 convalescent adults during the first 250 days after onset of symptoms.
Methods: We measured antibody responses to the
Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?8370610&promed&0
No comments:
Post a Comment